ArticleOncotarget2017

Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy.

Min Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.